|
Index of reports
> Cases resulting in other serious reactions (9)
> Cases with Somnolence (3)
Below is the selection of adverse event reports related to Apokyn (Apomorphine) that includes cases resulting in other serious reactions where reactions include somnolence.
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-06-27
Patient: female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Hallucination, Visual, Paranoia, NO Therapeutic Response, Somnolence
Suspect drug(s):
Apokyn
Dosage: 0.2 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-08
Apokyn
Dosage: 0.4 ml qd subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-09
Apokyn
Dosage: 0.3 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-10
End date: 2007-06-10
Apokyn
Dosage: 0.2 ml 1x subcutaneous
Start date: 2007-06-11
End date: 2007-06-11
Apokyn
Dosage: 0.3 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-12
End date: 2007-06-12
Apokyn
Dosage: 0.2 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-13
End date: 2007-06-13
Other drugs received by patient: Effexor; Carbidopa and Levodopa; Gabapentin; Mirapex; Diclofenac; Vitamin B12 NOS; Vitamin D
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-06-27
Patient: female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Paranoia, Hallucination, Somnolence
Suspect drug(s):
Apokyn
Dosage: (0.2 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-08
Apokyn
Dosage: (0.4 ml qd subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-09
Apokyn
Dosage: (0.3 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-10
End date: 2007-06-10
Apokyn
Dosage: (0.2 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-11
End date: 2007-06-11
Apokyn
Dosage: (0.3 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-12
End date: 2007-06-12
Apokyn
Dosage: (0.2 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-13
End date: 2007-06-13
Other drugs received by patient: Effexor; Carbidopa and Levodopa; Vitamin B12 NOS; Mirapex; Diclofenac; Vitamin B12 NOS; Vitamin D
Adverse event in receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-03-13
Patient:
Adverse reactions / side effects: Dementia, Gait Disturbance, Somnolence, Labile Blood Pressure
Suspect drug(s):
Apokyn
Dosage: 0.2-0.3 ml, total 5 doses
Indication: Parkinson's Disease
Start date: 2006-11-13
End date: 2006-12-09
Tigan Capsules
Dosage: 300 mg, tid
Administration route: Oral
Indication: Antiemetic Supportive Care
Start date: 2006-11-09
End date: 2006-11-24
Tigan Capsules
Dosage: 300 mg, single
Administration route: Oral
Start date: 2006-12-07
End date: 2006-12-07
Other drugs received by patient: Carbidopa W / Levodopa; Carbidopa W / Levodopa; Sanctura; Aricept; Multivitamin / 00831701 /; Calcium; Vitamin C / 00008001 /
|
